Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7706206> ?p ?o }
Showing triples 1 to 43 of
43
with 100 triples per page.
- Q7706206 subject Q18924462.
- Q7706206 subject Q5856563.
- Q7706206 subject Q6376193.
- Q7706206 subject Q7108202.
- Q7706206 subject Q7145095.
- Q7706206 subject Q8390786.
- Q7706206 subject Q8727262.
- Q7706206 subject Q8792436.
- Q7706206 subject Q9536267.
- Q7706206 abstract "Tetrabamate (Atrium, G Tril, Sevrium) is a combination drug formulation of febarbamate, difebarbamate, and phenobarbital which was marketed in France and Spain and was used to treat anxiety and alcohol withdrawal-associated muscle tremors, agitation, and depression. It was largely, but not completely discontinued on April 4, 1997 after over 30 years of use due to reports of hepatitis and acute liver failure. The decision to restrict the use of the drug had been long-awaited.".
- Q7706206 wikiPageWikiLink Q1192530.
- Q7706206 wikiPageWikiLink Q131742.
- Q7706206 wikiPageWikiLink Q142.
- Q7706206 wikiPageWikiLink Q1437823.
- Q7706206 wikiPageWikiLink Q154430.
- Q7706206 wikiPageWikiLink Q1779868.
- Q7706206 wikiPageWikiLink Q18924462.
- Q7706206 wikiPageWikiLink Q206348.
- Q7706206 wikiPageWikiLink Q217094.
- Q7706206 wikiPageWikiLink Q223907.
- Q7706206 wikiPageWikiLink Q29.
- Q7706206 wikiPageWikiLink Q2914873.
- Q7706206 wikiPageWikiLink Q394129.
- Q7706206 wikiPageWikiLink Q407241.
- Q7706206 wikiPageWikiLink Q422899.
- Q7706206 wikiPageWikiLink Q42844.
- Q7706206 wikiPageWikiLink Q5275245.
- Q7706206 wikiPageWikiLink Q5439707.
- Q7706206 wikiPageWikiLink Q5856563.
- Q7706206 wikiPageWikiLink Q6376193.
- Q7706206 wikiPageWikiLink Q7108202.
- Q7706206 wikiPageWikiLink Q7145095.
- Q7706206 wikiPageWikiLink Q8390786.
- Q7706206 wikiPageWikiLink Q8727262.
- Q7706206 wikiPageWikiLink Q8792436.
- Q7706206 wikiPageWikiLink Q9536267.
- Q7706206 type ChemicalSubstance.
- Q7706206 type Drug.
- Q7706206 type ChemicalObject.
- Q7706206 type Thing.
- Q7706206 type Q8386.
- Q7706206 comment "Tetrabamate (Atrium, G Tril, Sevrium) is a combination drug formulation of febarbamate, difebarbamate, and phenobarbital which was marketed in France and Spain and was used to treat anxiety and alcohol withdrawal-associated muscle tremors, agitation, and depression. It was largely, but not completely discontinued on April 4, 1997 after over 30 years of use due to reports of hepatitis and acute liver failure. The decision to restrict the use of the drug had been long-awaited.".
- Q7706206 label "Tetrabamate".